Trial Profile
Suppression of breakthrough bleeding in levonorgestrel intrauterine system (Mirena system) users
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2010
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Metrorrhagia
- Focus Therapeutic Use
- Acronyms MUSE
- 01 Feb 2010 Results published in Human Reproduction.
- 23 Apr 2007 New trial record.